ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Male Hypogonadism Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2W13867
Home | Market Reports | Health| Men s Health
Global Male Hypogonadism Therapy Market Research Report 2023
BUY CHAPTERS

Global Male Hypogonadism Therapy Market Research Report 2025

Code: QYRE-Auto-2W13867
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
AbbVie
Novo Nordisk
Merck KGaA
Bayer
TEVA
Novartis
Abbott
Roche
Endo International
Ipsen S A
ANI Pharmaceuticals
TherapeuticsMD
Viatris

Male Hypogonadism Therapy Market Size

The global market for Male Hypogonadism Therapy was valued at US$ 1381 million in the year 2024 and is projected to reach a revised size of US$ 1266 million by 2031, growing at a CAGR of -1.3% during the forecast period.

Male Hypogonadism Therapy Market

Male Hypogonadism Therapy Market

Male hypogonadism, also known as testosterone deficiency, is a failure of the testes to produce the male sex hormone testosterone, sperm, or both. It can be due to a testicular disorder or the result of a disease process involving the hypothalamus and pituitary gland.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Male Hypogonadism Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Male Hypogonadism Therapy.
The Male Hypogonadism Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Male Hypogonadism Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Male Hypogonadism Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Male Hypogonadism Therapy Market Report

Report Metric Details
Report Name Male Hypogonadism Therapy Market
Accounted market size in year US$ 1381 million
Forecasted market size in 2031 US$ 1266 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen, ANI Pharmaceuticals, TherapeuticsMD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Male Hypogonadism Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Male Hypogonadism Therapy Market size in 2031?

Ans: The Male Hypogonadism Therapy Market size in 2031 will be US$ 1266 million.

Who are the main players in the Male Hypogonadism Therapy Market report?

Ans: The main players in the Male Hypogonadism Therapy Market are Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Viatris, Bayer, Teva, Novartis, Abbott, Roche, Endo International, Ipsen, ANI Pharmaceuticals, TherapeuticsMD

What are the Application segmentation covered in the Male Hypogonadism Therapy Market report?

Ans: The Applications covered in the Male Hypogonadism Therapy Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Male Hypogonadism Therapy Market report?

Ans: The Types covered in the Male Hypogonadism Therapy Market report are Parenteral, Transdermal, Oral, Others

Recommended Reports

Male Health Therapy

Hormone Therapy Drugs

Sexual & Reproductive Health

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Male Hypogonadism Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Parenteral
1.2.3 Transdermal
1.2.4 Oral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Male Hypogonadism Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Male Hypogonadism Therapy Market Perspective (2020-2031)
2.2 Global Male Hypogonadism Therapy Growth Trends by Region
2.2.1 Global Male Hypogonadism Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Male Hypogonadism Therapy Historic Market Size by Region (2020-2025)
2.2.3 Male Hypogonadism Therapy Forecasted Market Size by Region (2026-2031)
2.3 Male Hypogonadism Therapy Market Dynamics
2.3.1 Male Hypogonadism Therapy Industry Trends
2.3.2 Male Hypogonadism Therapy Market Drivers
2.3.3 Male Hypogonadism Therapy Market Challenges
2.3.4 Male Hypogonadism Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Male Hypogonadism Therapy Players by Revenue
3.1.1 Global Top Male Hypogonadism Therapy Players by Revenue (2020-2025)
3.1.2 Global Male Hypogonadism Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Male Hypogonadism Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Male Hypogonadism Therapy Revenue
3.4 Global Male Hypogonadism Therapy Market Concentration Ratio
3.4.1 Global Male Hypogonadism Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Therapy Revenue in 2024
3.5 Global Key Players of Male Hypogonadism Therapy Head office and Area Served
3.6 Global Key Players of Male Hypogonadism Therapy, Product and Application
3.7 Global Key Players of Male Hypogonadism Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Male Hypogonadism Therapy Breakdown Data by Type
4.1 Global Male Hypogonadism Therapy Historic Market Size by Type (2020-2025)
4.2 Global Male Hypogonadism Therapy Forecasted Market Size by Type (2026-2031)
5 Male Hypogonadism Therapy Breakdown Data by Application
5.1 Global Male Hypogonadism Therapy Historic Market Size by Application (2020-2025)
5.2 Global Male Hypogonadism Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Male Hypogonadism Therapy Market Size (2020-2031)
6.2 North America Male Hypogonadism Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Male Hypogonadism Therapy Market Size by Country (2020-2025)
6.4 North America Male Hypogonadism Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Male Hypogonadism Therapy Market Size (2020-2031)
7.2 Europe Male Hypogonadism Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Male Hypogonadism Therapy Market Size by Country (2020-2025)
7.4 Europe Male Hypogonadism Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Male Hypogonadism Therapy Market Size (2020-2031)
8.2 Asia-Pacific Male Hypogonadism Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Male Hypogonadism Therapy Market Size (2020-2031)
9.2 Latin America Male Hypogonadism Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Male Hypogonadism Therapy Market Size by Country (2020-2025)
9.4 Latin America Male Hypogonadism Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Male Hypogonadism Therapy Market Size (2020-2031)
10.2 Middle East & Africa Male Hypogonadism Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Male Hypogonadism Therapy Introduction
11.1.4 Eli Lilly Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Male Hypogonadism Therapy Introduction
11.2.4 Pfizer Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Male Hypogonadism Therapy Introduction
11.3.4 AbbVie Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Male Hypogonadism Therapy Introduction
11.4.4 Novo Nordisk Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Male Hypogonadism Therapy Introduction
11.5.4 Merck KGaA Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.5.5 Merck KGaA Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Male Hypogonadism Therapy Introduction
11.6.4 Viatris Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.6.5 Viatris Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Male Hypogonadism Therapy Introduction
11.7.4 Bayer Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Male Hypogonadism Therapy Introduction
11.8.4 Teva Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Male Hypogonadism Therapy Introduction
11.9.4 Novartis Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Male Hypogonadism Therapy Introduction
11.10.4 Abbott Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Male Hypogonadism Therapy Introduction
11.11.4 Roche Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Male Hypogonadism Therapy Introduction
11.12.4 Endo International Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Details
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Male Hypogonadism Therapy Introduction
11.13.4 Ipsen Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Details
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Male Hypogonadism Therapy Introduction
11.14.4 ANI Pharmaceuticals Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Details
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Male Hypogonadism Therapy Introduction
11.15.4 TherapeuticsMD Revenue in Male Hypogonadism Therapy Business (2020-2025)
11.15.5 TherapeuticsMD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
AbbVie
Novo Nordisk
Merck KGaA
Bayer
TEVA
Novartis
Abbott
Roche
Endo International
Ipsen S A
ANI Pharmaceuticals
TherapeuticsMD
Viatris
List of Tables
 Table 1. Global Male Hypogonadism Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Parenteral
 Table 3. Key Players of Transdermal
 Table 4. Key Players of Oral
 Table 5. Key Players of Others
 Table 6. Global Male Hypogonadism Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Male Hypogonadism Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Male Hypogonadism Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Male Hypogonadism Therapy Market Share by Region (2020-2025)
 Table 10. Global Male Hypogonadism Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Male Hypogonadism Therapy Market Share by Region (2026-2031)
 Table 12. Male Hypogonadism Therapy Market Trends
 Table 13. Male Hypogonadism Therapy Market Drivers
 Table 14. Male Hypogonadism Therapy Market Challenges
 Table 15. Male Hypogonadism Therapy Market Restraints
 Table 16. Global Male Hypogonadism Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Male Hypogonadism Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Male Hypogonadism Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism Therapy as of 2024)
 Table 19. Ranking of Global Top Male Hypogonadism Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Male Hypogonadism Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Male Hypogonadism Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Male Hypogonadism Therapy, Product and Application
 Table 23. Global Key Players of Male Hypogonadism Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Male Hypogonadism Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Male Hypogonadism Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Male Hypogonadism Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Male Hypogonadism Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Male Hypogonadism Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Male Hypogonadism Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Male Hypogonadism Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Male Hypogonadism Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Male Hypogonadism Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Male Hypogonadism Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Male Hypogonadism Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Male Hypogonadism Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Male Hypogonadism Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Male Hypogonadism Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Male Hypogonadism Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Male Hypogonadism Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Male Hypogonadism Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Male Hypogonadism Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Male Hypogonadism Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Eli Lilly Company Details
 Table 49. Eli Lilly Business Overview
 Table 50. Eli Lilly Male Hypogonadism Therapy Product
 Table 51. Eli Lilly Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 52. Eli Lilly Recent Development
 Table 53. Pfizer Company Details
 Table 54. Pfizer Business Overview
 Table 55. Pfizer Male Hypogonadism Therapy Product
 Table 56. Pfizer Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 57. Pfizer Recent Development
 Table 58. AbbVie Company Details
 Table 59. AbbVie Business Overview
 Table 60. AbbVie Male Hypogonadism Therapy Product
 Table 61. AbbVie Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 62. AbbVie Recent Development
 Table 63. Novo Nordisk Company Details
 Table 64. Novo Nordisk Business Overview
 Table 65. Novo Nordisk Male Hypogonadism Therapy Product
 Table 66. Novo Nordisk Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 67. Novo Nordisk Recent Development
 Table 68. Merck KGaA Company Details
 Table 69. Merck KGaA Business Overview
 Table 70. Merck KGaA Male Hypogonadism Therapy Product
 Table 71. Merck KGaA Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 72. Merck KGaA Recent Development
 Table 73. Viatris Company Details
 Table 74. Viatris Business Overview
 Table 75. Viatris Male Hypogonadism Therapy Product
 Table 76. Viatris Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 77. Viatris Recent Development
 Table 78. Bayer Company Details
 Table 79. Bayer Business Overview
 Table 80. Bayer Male Hypogonadism Therapy Product
 Table 81. Bayer Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 82. Bayer Recent Development
 Table 83. Teva Company Details
 Table 84. Teva Business Overview
 Table 85. Teva Male Hypogonadism Therapy Product
 Table 86. Teva Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 87. Teva Recent Development
 Table 88. Novartis Company Details
 Table 89. Novartis Business Overview
 Table 90. Novartis Male Hypogonadism Therapy Product
 Table 91. Novartis Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 92. Novartis Recent Development
 Table 93. Abbott Company Details
 Table 94. Abbott Business Overview
 Table 95. Abbott Male Hypogonadism Therapy Product
 Table 96. Abbott Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 97. Abbott Recent Development
 Table 98. Roche Company Details
 Table 99. Roche Business Overview
 Table 100. Roche Male Hypogonadism Therapy Product
 Table 101. Roche Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 102. Roche Recent Development
 Table 103. Endo International Company Details
 Table 104. Endo International Business Overview
 Table 105. Endo International Male Hypogonadism Therapy Product
 Table 106. Endo International Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 107. Endo International Recent Development
 Table 108. Ipsen Company Details
 Table 109. Ipsen Business Overview
 Table 110. Ipsen Male Hypogonadism Therapy Product
 Table 111. Ipsen Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 112. Ipsen Recent Development
 Table 113. ANI Pharmaceuticals Company Details
 Table 114. ANI Pharmaceuticals Business Overview
 Table 115. ANI Pharmaceuticals Male Hypogonadism Therapy Product
 Table 116. ANI Pharmaceuticals Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 117. ANI Pharmaceuticals Recent Development
 Table 118. TherapeuticsMD Company Details
 Table 119. TherapeuticsMD Business Overview
 Table 120. TherapeuticsMD Male Hypogonadism Therapy Product
 Table 121. TherapeuticsMD Revenue in Male Hypogonadism Therapy Business (2020-2025) & (US$ Million)
 Table 122. TherapeuticsMD Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Male Hypogonadism Therapy Picture
 Figure 2. Global Male Hypogonadism Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Male Hypogonadism Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Parenteral Features
 Figure 5. Transdermal Features
 Figure 6. Oral Features
 Figure 7. Others Features
 Figure 8. Global Male Hypogonadism Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Male Hypogonadism Therapy Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Drugstores Case Studies
 Figure 12. Others Case Studies
 Figure 13. Male Hypogonadism Therapy Report Years Considered
 Figure 14. Global Male Hypogonadism Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Male Hypogonadism Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Male Hypogonadism Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Male Hypogonadism Therapy Market Share by Players in 2024
 Figure 18. Global Top Male Hypogonadism Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Male Hypogonadism Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Male Hypogonadism Therapy Revenue in 2024
 Figure 20. North America Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Male Hypogonadism Therapy Market Share by Country (2020-2031)
 Figure 22. United States Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Male Hypogonadism Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Male Hypogonadism Therapy Market Share by Region (2020-2031)
 Figure 34. China Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Male Hypogonadism Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Male Hypogonadism Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Male Hypogonadism Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Eli Lilly Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 51. AbbVie Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 52. Novo Nordisk Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 53. Merck KGaA Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 54. Viatris Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 55. Bayer Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 56. Teva Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 57. Novartis Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 58. Abbott Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 59. Roche Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 60. Endo International Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 61. Ipsen Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 62. ANI Pharmaceuticals Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 63. TherapeuticsMD Revenue Growth Rate in Male Hypogonadism Therapy Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Hypogonadism Treatment Market Research Report 2025
Global Hypogonadism Drug Market Research Report 2025
Global Growth Hormone Deficiency Therapy Market Insights Forecast to 2030
Global Testosterone Replacement Injectables Market Research Report 2024
Global Androgen Suppression Therapy Market Insights Forecast to 2030
Global Male Infertility Treatment Market Insights Forecast to 2030
Global Testosterone Replacement Therapy Market Insights Forecast to 2030
Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2030
Growth Hormone Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Testosterone Nasal Gel Market Research Report 2024
Global Hormone Replacement Therapy Market Insights Forecast to 2030
Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030
Testosterone Gel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Testosterone Hormone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypoactive Sexual Desire Disorder HSDD Treatment Market Insights Forecast to 2030
Global Drugs For Hormonal Replacement Market Insights Forecast to 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Global Male Infertility Market Research Report 2024
Global Cancer Hormone Therapy Drugs Market Insights Forecast to 2030
Global Oral Testosterone Market Research Report 2025

RELATED REPORTS

Global Absorbable Tissue Spacer for Prostate Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-31G16420
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Diagnosis and Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35S9798
Sat Sep 20 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia (BPH) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24N1059
Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Global Testosterone Undecylate (TU) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1F6137
Mon Sep 15 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions